Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was CAD 0.791139 million compared to CAD 0.087618 million a year ago. Net loss was CAD 0.573439 million compared to CAD 1.5 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.